Bloom Science’s Live Biotherapeutic BL-001 achieves significant weight loss in Phase 1 trial

Positive results from Phase 1 trial of BL-001, an innovative live biotherapeutic product (LBP) designed to replicate the metabolic effects of the ketogenic diet.

Global study reveals gaps in microbiota research

A new database of thousands of gut microbiota samples from across the word highlights the need for more diverse microbiota research across the globe.

Ferring receives health Canada approval for REBYOTA

The approval is major step forward in the fight against recurrent C. diff infection.

Vaginal microbiota may be linked to increased Chlamydia infection risk

Certain features of the vaginal microbiota, including specific bacterial communities, could indicate an increased Chlamydia infection risk.

BiomX Secures $12 Million to Drive Phage Therapy Advancements for Cystic Fibrosis Treatment

Financing will also support analysis of real-world evidence in people with CF to explore the relationship between P. aeruginosa reduction and clinical outcomes.

Redefining bacterial therapies with CRISPR: Ancillia’s strategy for enhanced efficacy

David Paez-Espino, Co-founder & CTO at Ancilia Biosciences, discusses the use of CRISPR technology to develop a new class of bacterial therapies that address critical gaps in microbiome-based treatments. 

Seres Therapeutics takes key step toward SER-155 approval with positive FDA feedback on bloodstream infection prevention

Seres Therapeutics, a leader in the live biotherapeutics space, has received pivotal feedback from the U.S. Food and Drug Administration (FDA) regarding the development of its lead investigational treatment, SER-155,…

A high-fiber diet and beneficial bacteria may improve metabolic health

Researchers have developed a new approach to restore the gut microbiota by combining a high-fiber, plant-based diet with supplementation of beneficial microbes such as Limosilactobacillus reuteri.

Gut microbes protect against colorectal cancer by regulating tumor-promoting gene

The microbiota plays a protective role against colorectal cancer by regulating Snhg9.

The vaginal microbiome

Understanding the vaginal microbiome is essential not only for treating gynecological conditions but also for preventing them and promoting overall well-being.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top